SCHEMBL19785366

SCHEMBL19785366

CN(C)c1ccc(-c2ccc(N(C)C)cc2Cl)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.48
TSHR P16473 4/20 0.48
ALOX15 P16050 3/20 0.48
HSD17B10 Q99714 2/20 0.48
TERT O14746 1/20 0.43
APP P05067 1/20 0.43
SLC2A1 P11166 1/20 0.39
MAPK1 P28482 4/20 0.39
TDP1 Q9NUW8 3/20 0.39
CYP3A4 P08684 2/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 3/20 0.37
LMNA P02545 2/20 0.37
KMT2A Q03164 2/20 0.37
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
PDK2 Q15119 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2056277 0.82 ALDH1A1 (0.50) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL10897063 0.79 ALDH1A1 (0.35) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL10706838 0.79 MAPT (0.38) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL31366224 0.78 CYP3A4 (0.48) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL10153909 0.78 CYP3A4 (0.48) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL3789309 0.78 ALDH1A1 (0.46) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL8621100 0.76 APP (0.42) TERTAPPHPGDMAPTLMNA
SCHEMBL3212678 0.76 HSD17B10 (0.50) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL9322910 0.76 ALDH1A1 (0.43) ALDH1A1TSHRALOX15HSD17B10TERT
SCHEMBL30016960 0.76 ALDH1A1 (0.43) ALDH1A1TSHRALOX15HSD17B10TERT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246415-B2 Process for preparing carbazoles DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-02 US disclosed
WO-2018013067-A1 PROCESS FOR PREPARING CARBAZOLES DOW GLOBAL TECHNOLOGIES LLC (US) 2018-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246415-B2 Process for preparing carbazoles DCLK2, DCLK1, PDCD2L ALDH1A1 1221/4885TSHR 2754/4885ALOX15 4585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.